SPY369.06+2.37 0.65%
DIA301.98+1.92 0.64%
IXIC12,446.22+69.04 0.56%

Burning Rock Biotech Q3 EPS $(0.18) Misses $(0.12) Estimate, Sales $18.25M Beat $18.09M Estimate

Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.12) by 50 percent. The company reported quarterly sales of $18.25 million which beat

· 11/20/2020 06:03
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.12) by 50 percent. The company reported quarterly sales of $18.25 million which beat the analyst consensus estimate of $18.09 million by 0.86 percent.